Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial

BACKGROUND: Chronic hepatitis B (CHB) can progress to cirrhosis, hepatocellular carcinoma (HCC) and ultimately liver-related death. Although oral antiviral therapy for patients with CHB reduces the risk of such complications, once cirrhosis is established, the benefits of antiviral therapy are not r...

詳細記述

保存先:
書誌詳細
出版年:Trials
主要な著者: Qu, Jianhui, Yu, Zujiang, Li, Qin, Chen, Yongping, Xiang, Dedong, Tan, Lin, Lei, Chunliang, Bai, Wenlin, Li, Hongyan, Shang, Qinghua, Chen, Liang, Hu, Xiaoyu, Lu, Wei, Li, Zhiqin, Chen, Da, Wang, Xiaodong, Zhang, Changjiang, Xiao, Guangming, Qi, Xun, Chen, Jing, Zhou, Li, Chen, Guofeng, Li, Yonggang, Zeng, Zhen, Rong, Guanghua, Dong, Zheng, Chen, Yan, Lou, Min, Wang, Chunping, Lu, Yinying, Zhang, Cuihong, Yang, Yongping
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2014
主題:
Study Protocol
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4234899/
https://ncbi.nlm.nih.gov/pubmed/25381721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-438
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料